（文章来源：证券日报） 证券日报网讯博苑股份9月11日在互动平台回答投资者提问时表示，截至2025年9月10日，公司股东总户 数为10，228户。 ...

证券日报网讯博苑股份（301617）9月11日在互动平台回答投资者提问时表示，公司碘化物产品，目前 主要应用于医药、化工、光电材料、饲料、食品等领域，暂未在固态电池领域实现销售。公司将围绕自 身主营业务，积极探索新产业（300832）领域应用场景，开展可行性研究，并在稳妥的基础上探索尝试 新业务领域。 ...

Core Viewpoint - The company, Boyuan Co., Ltd. (301617.SZ), is currently focusing on its main business of iodides, which are primarily used in pharmaceuticals, chemicals, optoelectronic materials, feed, and food sectors, and has not yet achieved sales in the solid-state battery field [1] Group 1 - The company's iodide products are mainly applied in various industries including pharmaceuticals, chemicals, optoelectronic materials, feed, and food [1] - The company has not yet realized sales in the solid-state battery sector [1] - The company plans to explore new industry applications and conduct feasibility studies while maintaining a cautious approach [1]

Group 1 - A total of 772 stocks reported their latest shareholder numbers as of August 31, with 386 stocks showing a decrease compared to the previous period [1][3] - The stocks with the largest decline in shareholder numbers include Boyuan Co., which saw a decrease of 26.59% to 9,715 shareholders, and Yalian Machinery, which decreased by 25.51% to 7,337 shareholders [3][4] - The average performance of concentrated stocks from the last period showed a 2.47% increase since August 11, which is lower than the Shanghai Composite Index's 4.87% increase during the same period [2] Group 2 - Among the stocks with a decline of over 10% in shareholder numbers, 56 stocks were identified, with Boyuan Co. leading the decline [3][4] - The stock with the highest increase since the concentration of shares is Anpeilong, which rose by 52.93% since August 11 [2] - The concentrated stocks are primarily from the machinery, basic chemicals, and electric equipment industries, with 49, 44, and 32 stocks respectively [3]

Group 1 - Dematech won a 900 million yuan overseas smart logistics project from a well-known e-commerce giant in Latin America, focusing on intelligent logistics cross-belt sorting systems and related services [1] - Kang En Bei received approval for the registration of short-term financing bonds and medium-term notes, with a total registration amount of 1 billion yuan, valid for two years [1][2] - Zhi Xiang Jin Tai's GR1803 injection for systemic lupus erythematosus clinical trial has been approved by the National Medical Products Administration [2] Group 2 - Jin Da Wei's subsidiary received approval for a veterinary drug product, pyridone, valid from September 3, 2025, to September 2, 2030 [4] - Fu Li Wang's subsidiary plans to invest 500 million yuan in a high-end wire material project, focusing on high-strength prestressed steel strands for various applications [5] - He Li Biological's subsidiary's Class III medical device registration application has been accepted, focusing on natural bone repair materials [12] Group 3 - Lin Yang Energy won a 244 million yuan metering equipment project from Southern Power Grid, expected to positively impact its 2025 and 2026 performance [20] - Sanxia Water plans to absorb its wholly-owned subsidiary, Chongqing Changdian United Energy, with all assets and liabilities to be inherited by Sanxia Water [13] - Tian Cheng Technology canceled the use of 91 million yuan of raised funds for permanent working capital, ensuring no impact on the normal operation of investment projects [24] Group 4 - Baosteel received approval to publicly issue bonds totaling 20 billion yuan to professional investors, valid for 24 months [52] - Tian Kang Biological reported a 10.15% year-on-year increase in pig sales in August, with a total of 263,800 pigs sold [53] - Xinjiang Construction won multiple major projects totaling 4.506 billion yuan, including a 2.4 billion yuan photovoltaic hydrogen synthesis project [18]

博苑股份9月9日交易公开信息 博苑股份今日上涨15.24%，全天换手率27.71%，成交额7.30亿元，振幅24.56%。龙虎榜数据显示，机构 净买入5754.35万元，深股通净卖出3063.74万元，营业部席位合计净买入878.44万元。 深交所公开信息显示，当日该股因日收盘价涨幅达15.24%上榜，机构专用席位净买入5754.35万元，深 股通净卖出3063.74万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交3.08亿元，其中，买入成交额为1.72亿 元，卖出成交额为1.36亿元，合计净买入3569.06万元。 具体来看，今日上榜的营业部中，共有4家机构专用席位现身，即买二、买三、买五、卖四、卖五，合 计买入金额8114.83万元，卖出金额2360.48万元，合计净买入5754.35万元，深股通为第一大买入营业部 及第一大卖出营业部，买入金额为5337.84万元，卖出金额为8401.58万元，合计净卖出3063.74万元。 资金流向方面，今日该股主力资金净流入3444.01万元，其中，特大单净流出394.10万元，大单资金净流 入3838.11万元。近5日主力资金净流出393.04万元。 ...

Core Viewpoint - The company announced that its stock price has experienced a significant deviation, with a cumulative increase of over 30% in closing prices over three consecutive trading days, indicating abnormal trading activity [1] Group 1: Stock Performance - The company's stock price has shown a cumulative increase of over 30% in closing prices over three consecutive trading days, which is classified as abnormal trading activity according to Shenzhen Stock Exchange regulations [1] Group 2: Business Focus - The company has noted a heightened market interest in solid-state battery-related concepts, although its iodide products are currently applied in pharmaceuticals, chemicals, optoelectronic materials, feed, and food sectors, with no sales in the solid-state battery field yet [1] - The company plans to actively explore new industry application scenarios and conduct feasibility studies while focusing on its core business [1]

智通财经APP讯，博苑股份(301617.SZ)发布股价异动公告称，公司关注到近期市场对于固态电池相关概 念的关注度较高，公司碘化物产品，目前主要应用于医药、化工、光电材料、饲料、食品等领域，暂未 在固态电池领域实现销售。公司将围绕自身主营业务，积极探索新产业领域应用场景，开展可行性研 究，并在稳妥的基础上探索尝试新业务领域。 ...

博苑股份发布异动公告，公司股票交易价格于2025年9月5日、9月8日、9月9日连续三个交易日收盘价涨 幅偏离值累计超过30%，属于股票交易异常波动。经核实，公司经营正常，近期未发生重大变化，未发 现公共传媒报道可能或已对公司股票交易价格产生较大影响的未公开重大信息。公司控股股东及实际控 制人不存在关于公司应披露而未披露的重大事项或处于筹划阶段的重大事项。同时，公司关注到近期市 场对于固态电池相关概念的关注度较高，但公司碘化物产品目前主要应用于医药、化工、光电材料、饲 料、食品等领域，暂未在固态电池领域实现销售。公司将围绕自身主营业务，积极探索新产业领域应用 场景，开展可行性研究，并在稳妥的基础上探索尝试新业务领域。 ...

证券代码：301617 证券简称：博苑股份 公告编号：2025-047 山东博苑医药化学股份有限公司 关于股票交易异常波动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的具体情况 山东博苑医药化学股份有限公司（以下简称"公司"）股票交易价格于 2025 年 9 月 5 日、9 月 8 日、9 月 9 日连续三个交易日收盘价涨幅偏离值累计超过 30%， 根据深圳证券交易所相关规定，属于股票交易异常波动的情况。 二、公司关注并核实情况的说明 针对公司股票交易异常波动情况，公司对控股股东、实际控制人、全体董事 及高级管理人员就相关问题进行了核实，现将相关情况说明如下： （一）公司未发现前期披露的信息存在需要更正、补充之处。 （二）公司目前经营正常，近期公司经营情况及内外部经营环境未发生重大 变化。 （三）公司未发现近期公共传媒报道了可能或已经对公司股票交易价格产生 较大影响的未公开重大信息。 （四）公司、控股股东及实际控制人不存在关于公司应披露而未披露的重大 事项或处于筹划阶段的重大事项。 （五）股票异常波动期间，公司控股股东及实际控制 ...